Thomas Baker (Biosciences) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 21-12-2024
- Paid Up Capital ₹ 1.50 M
as on 21-12-2024
- Company Age 36 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 30.27 Cr
as on 21-12-2024
- Satisfied Charges ₹ 24.21 Cr
as on 21-12-2024
- Revenue -7.72%
(FY 2023)
- Profit -45.33%
(FY 2023)
- Ebitda -116.61%
(FY 2023)
- Net Worth -10.20%
(FY 2023)
- Total Assets -58.07%
(FY 2023)
About Thomas Baker (Biosciences)
The Corporate was formerly known as Miss Cherie Cosmetics Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹30.27 Cr. The company has closed loans amounting to ₹24.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Umesh Rastogi and Bela Rastogi serve as directors at the Company.
- CIN/LLPIN
U74997MH1988PTC047597
- Company No.
047597
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Thomas Baker (Biosciences)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Rastogi  | Director | 30-Sep-1991 | Current |
| Bela Rastogi | Director | 03-Jun-1988 | Current |
Financial Performance of Thomas Baker (Biosciences).
Thomas Baker (Biosciences) Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.72% decrease. The company also saw a substantial fall in profitability, with a 45.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thomas Baker (Biosciences)?
Unlock access to Thomas Baker (Biosciences)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Thomas Baker (Chemicals) Private LimitedActive 44 years 1 monthUmesh Rastogi and Bela Rastogi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Aug 2024 | ₹17.90 Cr | Open |
Axis Bank Limited Creation Date: 18 Nov 2019 | ₹2.00 M | Open |
Others Creation Date: 27 Sep 2018 | ₹12.17 Cr | Open |
How Many Employees Work at Thomas Baker (Biosciences)?
Unlock and access historical data on people associated with Thomas Baker (Biosciences), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thomas Baker (Biosciences), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thomas Baker (Biosciences)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
